Your browser doesn't support javascript.
loading
MYO10 regulates genome stability and cancer inflammation through mediating mitosis.
Mayca Pozo, Franklin; Geng, Xinran; Miyagi, Masaru; Amin, Amanda L; Huang, Alex Y; Zhang, Youwei.
Afiliación
  • Mayca Pozo F; Department of Pharmacology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA. Electronic address: fxm130@case.edu.
  • Geng X; Department of Pharmacology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA.
  • Miyagi M; Department of Pharmacology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA.
  • Amin AL; Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
  • Huang AY; Center for Pediatric Immunotherapy at Rainbow, Angie Fowler AYA Cancer Institute, University Hospitals, Cleveland, OH 44106, USA; Division of Pediatric Hematology/Oncology, University Hospitals Rainbow Babies & Children's Hospital, Cleveland, OH 44106, USA; Department of Pediatrics, Case Western
  • Zhang Y; Department of Pharmacology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA. Electronic address: yxz169@case.edu.
Cell Rep ; 42(5): 112531, 2023 05 30.
Article en En | MEDLINE | ID: mdl-37200188
ABSTRACT
Genomic instability can promote inflammation and tumor development. Previous research revealed an unexpected layer of regulation of genomic instability by a cytoplasmic protein MYO10; however, the underlying mechanism remained unclear. Here, we report a protein stability-mediated mitotic regulation of MYO10 in controlling genome stability. We characterized a degron motif and phosphorylation residues in the degron that mediate ß-TrCP1-dependent MYO10 degradation. The level of phosphorylated MYO10 protein transiently increases during mitosis, which is accompanied by a spatiotemporal cellular localization change first accumulating at the centrosome then at the midbody. Depletion of MYO10 or expression of MYO10 degron mutants, including those found in cancer patients, disrupts mitosis, increases genomic instability and inflammation, and promotes tumor growth; however, they also increase the sensitivity of cancer cells to Taxol. Our studies demonstrate a critical role of MYO10 in mitosis progression, through which it regulates genome stability, cancer growth, and cellular response to mitotic toxins.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mitosis / Neoplasias Límite: Humans Idioma: En Revista: Cell Rep Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mitosis / Neoplasias Límite: Humans Idioma: En Revista: Cell Rep Año: 2023 Tipo del documento: Article